Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma is a research paper published in Neuro-Oncology Advances (2021). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: CA178499
National Institutes of Health
Grant: P30CA054174-17
National Institutes of Health
Grant: 5R01CA178499-05
Novel ERbeta agonists for the treatment of gliomas
National Institutes of Health
Grant: 5P30CA054174-16
SAN ANTONIO CANCER INSTITUTE
FWCI
1.03
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance
Additional file 1 of SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance